Neurocrine Biosciences reported $2.01B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
ALKERMES ALKS:US $ 1957.42M 20.43M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
Aptinyx Inc APTX:US $ 92.31M 14.35M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Cytokinetics CYTK:US $ 771.72M 84.54M
Dynavax Technologies DVAX:US $ 1023M 14.02M
Enanta Pharmaceuticals ENTA:US $ 385.21M 21.6M
Exelixis EXEL:US $ 2881.4M 227.29M
Gilead Sciences GILD:US $ 62870M 210M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Intra Cellular Therapies ITCI:US $ 811.91M 56.67M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Prothena PRTA:US $ 549.59M 31.82M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Repligen RGEN:US $ 2444.92M 61.09M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
Xoma XOMA:US $ 154.22M 4.94M
YTE INCY:US $ 5319.04M 264.81M